Literature DB >> 20718802

Faecal carriage of extended-spectrum β-lactamase-producing and AmpC β-lactamase-producing bacteria among Danish army recruits.

A M Hammerum1, C H Lester, L Jakobsen, L J Porsbo.   

Abstract

During May and June 2008, 84 Danish army recruits were tested for faecal carriage of extended-spectrum β-lactamase (ESBL)-producing and AmpC β-lactamase-producing bacteria. Three ESBL-producing (CTX-M-14a) Escherichia coli isolates, two AmpC-producing (CMY-2) E. coli isolates and one AmpC-producing (CMY-34) Citrobacter freundii isolate were detected. Two of the CTX-M-14a E. coli isolates had similar pulsed-field gel electrophoresis and multilocus sequence typing profiles, indicating the same origin or transmission between the two army recruits. The bla(CTX-M-14a) genes were transferable to an E. coli recipient. These commensal bacteria therefore constitute a reservoir of resistance genes that can be transferred to other pathogenic bacteria in the intestine.
© 2010 The Authors. Clinical Microbiology and Infection © 2010 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20718802     DOI: 10.1111/j.1469-0691.2010.03340.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  9 in total

1.  Faecal carriage of extended-spectrum β-lactamase-producing enterobacteria among soldiers at admission in a French military hospital after aeromedical evacuation from overseas.

Authors:  F Janvier; H Delacour; S Tessé; S Larréché; N Sanmartin; D Ollat; C Rapp; A Mérens
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-08       Impact factor: 3.267

2.  Host-Specific Patterns of Genetic Diversity among IncI1-Iγ and IncK Plasmids Encoding CMY-2 β-Lactamase in Escherichia coli Isolates from Humans, Poultry Meat, Poultry, and Dogs in Denmark.

Authors:  Katrine Hartung Hansen; Valeria Bortolaia; Christine Ahl Nielsen; Jesper Boye Nielsen; Kristian Schønning; Yvonne Agersø; Luca Guardabassi
Journal:  Appl Environ Microbiol       Date:  2016-07-15       Impact factor: 4.792

Review 3.  Trends in human fecal carriage of extended-spectrum β-lactamases in the community: toward the globalization of CTX-M.

Authors:  Paul-Louis Woerther; Charles Burdet; Elisabeth Chachaty; Antoine Andremont
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

4.  Multidrug-resistant bacteria as intestinal colonizers and evolution of intestinal colonization in healthy university students in Portugal.

Authors:  Raquel Mota; Marisa Pinto; Josman Palmeira; Daniela Gonçalves; Helena Ferreira
Journal:  Access Microbiol       Date:  2020-11-25

5.  Carriage of ESBL/AmpC-producing or ciprofloxacin non-susceptible Escherichia coli and Klebsiella spp. in healthy people in Norway.

Authors:  Charlotte R Ulstad; Margrete Solheim; Sophie Berg; Morten Lindbæk; Ulf R Dahle; Astrid L Wester
Journal:  Antimicrob Resist Infect Control       Date:  2016-12-15       Impact factor: 4.887

6.  Characteristics of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae and Contact to Animals in Estonia.

Authors:  Kaidi Telling; Age Brauer; Mailis Laht; Piret Kalmus; Karolin Toompere; Veljo Kisand; Matti Maimets; Maido Remm; Tanel Tenson; Irja Lutsar
Journal:  Microorganisms       Date:  2020-07-27

7.  Fecal Colonization with Extended-Spectrum Beta-Lactamase and AmpC-Producing Escherichia coli.

Authors:  Mohamed H Al-Agamy; Taghrid S El Mahdy; Atef M Shibl
Journal:  Biomed Res Int       Date:  2016-05-31       Impact factor: 3.411

Review 8.  Escherichia coli β-Lactamases: What Really Matters.

Authors:  Priyanka Bajaj; Nambram S Singh; Jugsharan S Virdi
Journal:  Front Microbiol       Date:  2016-03-30       Impact factor: 5.640

9.  Epidemiological characteristics of carbapenem-resistant Enterobacteriaceae collected from 17 hospitals in Nanjing district of China.

Authors:  Hui Zhou; Kui Zhang; Wei Chen; Junhao Chen; Jie Zheng; Chang Liu; Li Cheng; Wanqing Zhou; Han Shen; Xiaoli Cao
Journal:  Antimicrob Resist Infect Control       Date:  2020-01-13       Impact factor: 4.887

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.